Surging BD transactions and policy catalysts! The Hang Seng Medicine ETF (159892) surged by 3.67%, while the HK Connect Healthcare ETF (520510) rose by 2.89%, with its real-time turnover rate ranking first among similar products.

Gelonghui, March 6th | Today, the innovative drug sector rebounded strongly. The constituent stock 3SBio Inc. surged by 10%, driving the Hang Seng Medicine ETF (159892) to rise by 3.67%. The Stock Connect Healthcare ETF (520510) increased by 2.89%, with a turnover rate of 54.58%, ranking first among similar products. In terms of news: ① The 2026 Government Work Report identifies new quality productive forces as a core focus, listing biomedicine alongside integrated circuits, aerospace, and low-altitude economy for the first time, clearly defining it as a national 'emerging pillar industry.' It is expected that innovative drugs will receive more concentrated policy support, funding, and resource allocation. ② Business development (BD) transactions continue.

Gelonghui FinanceMar 6 13:01

ETF Market Review | AI hardware stocks lead the rally, with the China-Korea Semiconductor ETF nearing the daily limit.

Gelonghui, February 26 | The three major indices of the A-share market showed mixed performance today. At the close, the Shanghai Composite Index fell by 0.01%, the Shenzhen Component Index rose by 0.19%, and the ChiNext Index dropped by 0.29%. The Beijing Stock Exchange 50 Index declined by 0.15%. The total trading volume of the Shanghai, Shenzhen, and Beijing markets reached 2.5566 trillion yuan, an increase of 75.7 billion yuan compared to the previous day, with more than 2,400 stocks posting gains. In terms of sector performance, notable increases were observed in CPO, copper-cable high-speed connectivity, optical fiber, PCB, liquid-cooled servers, wind power equipment, aviation engines, lab-grown diamonds, semiconductors, and sugar substitute concept stocks. Conversely, declines were seen in cinema chains, insurance, real estate, short-form video games, automobile manufacturing, precious metals, and other sectors.

Gelonghui FinanceFeb 26 15:17

Mass production of brain-computer interfaces to begin in 2026! The Hang Seng Medical ETF (159892) surged by 6%, with a 'brain-computer interface' exposure exceeding 20%. The Medical Device ETF (562600) rose by 5.6%.

Gelonghui, January 5th | On the first trading day of A-shares in 2026, the brain-computer interface sector experienced a strong surge. Component stocks such as Botuoshengwu, Sainuo Medical, and Xiangyu Medical collectively hit the “20CM” limit-up, driving the Medical Device ETF up by 5.6%. The Hong Kong stock medical sector also saw broad gains, with the Hang Seng Pharma ETF and the HK Stock Connect Medical ETF rising by 6% and 5.7%, respectively. News highlights: ① Elon Musk recently stated on social media that his brain-computer interface company Neuralink will begin “mass production” of brain-computer interface devices in 2026. ② According to CCTV, in 2025, China has already approved innovative products for market entry.

Gelonghui FinanceJan 5 14:47

Just now, a major futures index was released!

The Resonance Between Derivatives and ETFs

Gelonghui FinanceNov 28, 2025 15:19

Express News | The entire pharmaceutical sector in the Hong Kong stock market has strengthened, with the Hang Seng Pharmaceutical ETF rising over 2%.

BreakingsNov 26, 2025 11:08

Intelligent Market Analysis of Hong Kong Stocks | Price Hike Themes Dominate the Market, Technology Stocks Begin to Show Signs of Recovery

Today, both markets opened lower but surged significantly, with the Shanghai Composite Index breaking through the 4,000-point mark to reach a ten-year high. The Hang Seng Index also surpassed the 27,000-point level, coming within less than 300 points of this year's peak, while trading volume exceeded 270 billion Hong Kong dollars.

Zhitong FinanceNov 13, 2025 20:15